Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Gradishar

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Cancer|January 26, 2006
Landmark trials in endocrine adjuvant therapy for breast carcinomaWilliam Gradishar
Expert Review of Anticancer Therapy|July 9, 2005
Fulvestrant in the treatment of postmenopausal women with advanced breast cancerWilliam Gradishar
Oncology (Williston Park, N.Y.)|February 5, 2010
Skeletal issues and bone health in patients with cancer. IntroductionWilliam Gradishar
Drug Design, Development and Therapy|November 19, 2009
Management of advanced breast cancer with the epothilone B analog, ixabepiloneWilliam Gradishar
Breast (Edinburgh, Scotland)|March 21, 2008
Fulvestrant: expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancerStephen Chia, William Gradishar
CA: a Cancer Journal for Clinicians|September 5, 2009
New molecular classifications of breast cancerMary Cianfrocca, William Gradishar
BMJ (Clinical Research Ed.)|February 19, 2002
Breast cancerMonica Morrow, William Gradishar
Journal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
NCCN Guidelines Update: Breast CancerWilliam Gradishar, Kilian E Salerno
Current Opinion in Obstetrics & Gynecology|December 16, 2016
Breast cancer: updates and advances in 2016Sara B Giordano, William Gradishar
Breast Cancer Research and Treatment|June 5, 2009
nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trialGeorge Dranitsaris, Robert Coleman, William Gradishar
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Cancer|January 26, 2006
Landmark trials in endocrine adjuvant therapy for breast carcinomaWilliam Gradishar
Expert Review of Anticancer Therapy|July 9, 2005
Fulvestrant in the treatment of postmenopausal women with advanced breast cancerWilliam Gradishar
Oncology (Williston Park, N.Y.)|February 5, 2010
Skeletal issues and bone health in patients with cancer. IntroductionWilliam Gradishar
Drug Design, Development and Therapy|November 19, 2009
Management of advanced breast cancer with the epothilone B analog, ixabepiloneWilliam Gradishar
Breast (Edinburgh, Scotland)|March 21, 2008
Fulvestrant: expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancerStephen Chia, William Gradishar
CA: a Cancer Journal for Clinicians|September 5, 2009
New molecular classifications of breast cancerMary Cianfrocca, William Gradishar
BMJ (Clinical Research Ed.)|February 19, 2002
Breast cancerMonica Morrow, William Gradishar
Journal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
NCCN Guidelines Update: Breast CancerWilliam Gradishar, Kilian E Salerno
Current Opinion in Obstetrics & Gynecology|December 16, 2016
Breast cancer: updates and advances in 2016Sara B Giordano, William Gradishar
Breast Cancer Research and Treatment|June 5, 2009
nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trialGeorge Dranitsaris, Robert Coleman, William Gradishar
Pageof 8